Marengo Therapeutics Appoints Ke Liu, MD, PhD, and Bruce Chabner, MD, to Key Leadership Roles, Strengthening Marengo's Development Team and Supporting Translation to the Clinic

/PRNewswire/ -- Marengo Therapeutics, Inc., a company pioneering novel therapeutics that directly target the Vβ chain of the T cell receptor (TCR) to activate...

Related Keywords

China ,Henan ,Massachusetts ,United States ,Jacques Moisan ,Oncology Center ,National Cancer Institute ,Clinical Pharmacology Branch ,Office Of Tissues ,Novartis ,Clinical Oncology Program ,Oncology Branch ,Division Of Cancer Treatment ,Hospital Cancer Center ,National Cancer Advisory Board ,Drug Administration ,Professor Of Medicine At Harvard Medical School ,Cornell University ,Henan Medical University ,Laboratory Of Chemical Pharmacology ,Serono ,Stevena Rosenberg At National Cancer Institute ,Senior Vice President ,Advanced Therapies ,Biologics Evaluation ,Associate Director ,Gene Therapy ,Allen Distinguished Investigator ,Clinical Director Emeritus ,Massachusetts General Hospital Cancer Center ,Harvard Medical ,Senior Investigator ,Chemical Pharmacology ,Alyssa Marino ,Clinical Operations ,Vice President ,Marengo Therapeutics ,